Sub: Updated Memorandum of Association & Articles of Association of the Company
Ref.: Our intimation dated 1st September, 2022 - Update on the Scheme of Arrangement
With reference to our letter under reference, we had informed the exchange that the Hon'ble National Company Law Tribunal, Ahmedabad Bench vide its Order dated 29th August, 2022 has sanctioned the Scheme of Arrangement in the nature of Amalgamation between Aleor Dermaceuticals Limited and Alembic Pharmaceuticals Limited and their respective shareholders ("Scheme") pursuant to the provisions of Section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules made thereunder.
The updated Memorandum of Association ("MOA") & Articles of Association ("AOA") after giving effect to the Scheme is placed on the website of the Company at the following web-link:
https://alembicpharmaceuticals.com/moa-aoa/
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
CHARANDEEP SINGH SALUJA
Digitally signed by CHARANDEEP SINGH SALUJA DN: c=IN, o=Personal, pseudonym=a60bda6662cacaa6dee424354752c8af217d06e3e0b6cc73c4bb1a cdf09b43c5, postalCode=390008, st=GUJARAT, serialNumber=2df2425a9d726770b96178ea7d183d3b13c8557e9c4be4aaf902 36628eb533e7, cn=CHARANDEEP SINGH SALUJA
Alembic Pharmaceuticals Limited published this content on 14 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2022 14:19:03 UTC.
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
ALEMBIC PHARMACEUTICALS LIMITED 
